AmgenvsAmneal Pharmaceuticals

AMGN and AMRX stock compared: price, dividend, valuation and results, from SEC filings.

AMGN

Amgen Inc.

$462.32

Value $249B

-0.30%
AMGN's page

AMRX

Amneal Pharmaceuticals, Inc.

$21.23

Value $7.4B

-1.47%
AMRX's page

Amgen (AMGN) has a market value of $249B and Amneal Pharmaceuticals (AMRX) $7.4B. Over the last year, with dividends, AMGN moved +42.3% and AMRX +79.7%. The P/E is 26.5 for AMGN and 55.5 for AMRX. Dividend yield: AMGN 2.15%, AMRX none.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    AMGN$249B

    AMRX$7.4B

    AMGN is 34 times AMRX

  • Revenue, 12 months

    AMGN$38.9B

    AMRX$3.2B

    AMGN is 12 times AMRX

  • Net income, 12 months

    AMGN$9.4B

    AMRX$133M

    AMGN is 70 times AMRX

  • Operating margin

    AMGN32.4%

    AMRX15.0%

    17.4 points apart

  • ROIC

    AMGN16.2%

    AMRX16.7%

    0.5 points apart

  • P/E

    AMGN26.5

    AMRX55.5

    AMRX is 2.1 times AMGN

  • Dividend yield

    AMGN2.2%

    AMRX0.0%

    2.2 points apart

  • 5-year return

    AMGN+157.4%

    AMRX+310.4%

    153.0 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

AMGN+157.4%

AMRX+310.4%

20040020222023202420252026
Returns by period
PeriodAMGNWith dividendsAMRXWith dividends
1 year since November 12, 2025+42.3%Price +38.5%+79.7%Price +79.7%
3 years since November 13, 2023+91.0%+24.1% a yearPrice +74.6%+399.5%+70.9% a yearPrice +399.5%
5 years since November 12, 2021+157.4%+20.8% a yearPrice +120.3%+310.4%+32.6% a yearPrice +310.4%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

AMGNAmgenAMRXAmneal Pharmaceuticals

Valuation

AMGNAMRX
Valuation
Price$462.32$21.23
Market value$249B$7.4B
Enterprise value (EV)$290B$10.2B
P/E26.555.5
P/E, 5-year median23.0–
P/B17.413.9
EV/EBIT23.021.4
Free cash flow yield3.8%1.2%

Results and growth

AMGNAMRX
Results and growth
Revenue, 12 months$38.9B$3.2B
Net income, 12 months$9.4B$133M
Free cash flow, 12 months$9.6B$88M
Earnings per share, 12 months$17.25$0.42
Revenue growth, year on year10.0%8.1%
Revenue growth a year, past+7.6%over 5 years+8.7%over 5 years
EPS growth a year, past+2.9%over 5 years-18.5%over 5 years

Margins and returns on capital

AMGNAMRX
Margins and returns on capital
Gross margin70.9%40.2%
Operating margin32.4%15.0%
Net margin24.1%4.2%
ROIC16.2%16.7%
ROE87.8%196.8%

Balance sheet

AMGNAMRX
Balance sheet
Cash$13.2B$157M
Total debt$54.0B$3.0B
Net debt / EBITDA2.35.3
Interest cover4.8×–

Dividends and buybacks

AMGNAMRX
Dividends and buybacks
Dividend yield2.2%–
Dividend per share, 12 months$9.94–
Dividend growth a year, past+8.1%over 5 years–
Buyback yield––
Shareholder yield2.2%–

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: AMGN or AMRX

Didn't find what you were looking for?

Ask us
Which is bigger, Amgen or Amneal Pharmaceuticals?

By market value, Amgen ($249B) is about 33.7 times Amneal Pharmaceuticals ($7.4B), at today's prices.

How did AMGN and AMRX stock do over the last 5 years?

Since November 12, 2021, AMGN's price moved +120.3% and AMRX's +310.4%. With dividends: AMGN +157.4% (+20.8% a year), AMRX +310.4% (+32.6% a year). Past returns do not predict future ones.

Which pays the higher dividend, AMGN or AMRX?

The dividend yield at today's price is 2.15% for Amgen and none for Amneal Pharmaceuticals. Over the last twelve months they paid $9.94 and – per share.

What is the P/E of AMGN and AMRX?

At today's price, the P/E is 26.5 for AMGN and 55.5 for AMRX. It is the share price over the last twelve months' earnings per share.

Which has the higher profit margins, Amgen or Amneal Pharmaceuticals?

Over the last twelve months, the net margin was 24.1% for Amgen and 4.2% for Amneal Pharmaceuticals, and the operating margin 32.4% and 15.0%. Revenue was $38.9B and $3.2B.

Which is the better investment, Amgen or Amneal Pharmaceuticals?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.